Hemidiaphragmatic Paralysis Following Supraclavicular Brachial Plexus Blockade.

Launched by SOHAG UNIVERSITY · Jul 8, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a type of anesthesia called the supraclavicular brachial plexus block, which is used to numb the arm for surgery. The researchers want to understand if this technique can lead to a condition known as hemidiaphragmatic paralysis, which can affect breathing. This method has become more popular due to advancements in ultrasound technology, which helps doctors place the anesthesia more accurately. The goal is to provide effective pain relief while minimizing risks, especially respiratory issues.

To participate in this trial, you need to be between 18 and 60 years old, in generally good health (as classified by the American Society of Anesthesiologists), and have a body mass index (BMI) under 35. If you have certain health conditions, such as pregnancy, allergies to local anesthetics, or specific breathing problems, you may not be eligible. Participants will receive the supraclavicular block and will be monitored for any side effects related to breathing. This trial is important for improving anesthesia methods and ensuring patients' safety during arm surgeries.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age between 18 and 60 years. American Society of Anesthesiologists physical status 1 to 3, Able to give informed consent. Body mass index (BMI) less than 35.
• Exclusion Criteria:
• • Patient refusal. Known/suspected allergy to local anesthetics Pregnancy Body mass index (BMI) greater than 35 kg/m2 Neuromuscular disease Obstructive or restrictive pulmonary disease Known or suspected PNP or diaphragmatic dysfunction Other medical or anatomic contraindication to brachial plexus blockade as judged by the investigator
• • local infection.
• • significant coagulation abnormalities.